Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Pubmed ID :27352049
Publication Date : //
This study investigated the effects of matrix on the behaviors of 3D-cultured cells of two prostate cancer cell lines, LNCaP and DU145. Two biologically-derived matrices, Matrigel and Cultrex BME, and one synthetic matrix, the Alvetex scaffold, were used to culture the cells. The cell proliferation rate, cellular response to anti-cancer drugs, and expression levels of proteins associated with drug sensitivity/resistance were examined and compared amongst the 3D-cultured cells on the three matrices and 2D-cultured cells. The cellular responses upon treatment with two common anti-cancer drugs, Docetaxel and Rapamycin, were examined. The expressions of epidermal growth factor receptor (EGFR) and β-III tubulin in DU145 cells and p53 in LNCaP cells were examined. The results showed that the proliferation rates of cells cultured on the three matrices varied, especially between the synthetic matrix and the biologically-derived matrices. The drug responses and the expressions of drug sensitivity-associated proteins differed between cells on various matrices as well. Among the 3D cultures on the three matrices, increased expression of β-III tubulin in DU145 cells was correlated with increased resistance to Docetaxel, and decreased expression of EGFR in DU145 cells was correlated with increased sensitivity to Rapamycin. Increased expression of a p53 dimer in 3D-cultured LNCaP cells was correlated with increased resistance to Docetaxel. Collectively, the results showed that the matrix of 3D cell culture models strongly influences cellular behaviors, which highlights the imperative need to achieve standardization of 3D cell culture technology in order to be used in drug screening and cell biology studies.
Related products :
||Flutamide Flutamide(Eulexin) is an oral nonsteroidal antiandrogen drug primarily used to treat prostate cancer. For research use only.
||Drug susceptibility (secondary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method.
||Drug susceptibility (primary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method.
||Erlotinib Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. For research use only.
||Artemisinin Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria. For research use only.
||Prednisone Prednisone(Adasone) is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant drug. For research use only.
||Safinamide Mesylate Safinamide Mesylate is a candidate drug against Parkinson's disease with multiple methods of action. For research use only.
||IL21 protein IL21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigenspecific responses of immune cells. The biological effec
||Rat IL21 protein IL21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigen-specific responses of immune cells. The biological
||GDC-0449 Vismodegib is an investigational drug for the treatment of various types of cancer. For research use only.
||INCB018424 Ruxolitinib is a drug being investigated for the treatment of myeloproliferative diseases, plaque psoriasis, and various types of cancer. For research use only.
||ABT-888 Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor.It inhibits both PARP1 and PARP2. For research use only.
||Carboplatin This drug performed growth inhibitory activity in IGROV1 and OAW42 cells(IC50 of 25 and 30 mg_l,respectively). For research use only.
||NVP-AUY922 NVP-AUY922 is an experimental drug candidate for the treatment of cancer. For research use only.
||Gefitinib Gefitinib is a drug used in the treatment of certain types of cancer. For research use only.
||Oxaliplatin Oxaliplatin is a a third-generation, diaminocyclohexane-containing
platinum anti-cancer drug. For research use only.
||Doxorubicin Doxorubicin is a drug used in cancer chemotherapy. For research use only.
||Amonafide Amonafide is a drug used in the treatment of cancer. For research use only.
||Imatinib (free base) Imatinib (originally STI571) is a drug used to treat certain types of cancer. For research use only.
||Levamisole Hydrochloride Levamisole Hydrochloride(Ergamisol)is an antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by incr
||AnaPrep Cultured Cell DNA Extraction Kit (48) For extracting genomic DNA from up to 5x105 cultured cells
||1 kit (48 extractions) Including all required plastic disposables
||Drug Abuse urine Drug Abuse
||Lapatinib (free base) Lapatinib, used in the form of lapatinib ditosylate, (USAN) (Tykerb_Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. For research use only.
||Homo sapiens,Human,Metalloreductase STEAP2,PCANAP1,Prostate cancer-associated protein 1,Protein upregulated in metastatic prostate cancer,PUMPCn,Six-transmembrane epithelial antigen of prostate 2,SixT
||Canertinib Canertinib (CI-1033) is an experimental drug candidate for the treatment of cancer. It is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
email@example.com | Gentaur
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
firstname.lastname@example.org | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
email@example.com | Gentaur
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
email@example.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
firstname.lastname@example.org | Gentaur
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
Tel 02 36 00 65 93
Fax 02 36 00 65 94
email@example.com | Gentaur
Search in Google:
Share this page:
Enter catalog number :